These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 21331523

  • 1. Pretransplant serum ferritin is associated with bloodstream infections within 100 days of allogeneic stem cell transplantation for myeloid malignancies.
    Tachibana T, Tanaka M, Takasaki H, Numata A, Ito S, Watanabe R, Hyo R, Ohshima R, Hagihara M, Sakai R, Fujisawa S, Tomita N, Fujita H, Maruta A, Ishigatsubo Y, Kanamori H.
    Int J Hematol; 2011 Mar; 93(3):368-374. PubMed ID: 21331523
    [Abstract] [Full Text] [Related]

  • 2. Impact of pre-transplant serum ferritin on outcomes of patients with myelodysplastic syndromes or secondary acute myeloid leukaemia receiving reduced intensity conditioning allogeneic haematopoietic stem cell transplantation.
    Lim ZY, Fiaccadori V, Gandhi S, Hayden J, Kenyon M, Ireland R, Marsh J, Ho AY, Mufti GJ, Pagliuca A.
    Leuk Res; 2010 Jun; 34(6):723-7. PubMed ID: 19944463
    [Abstract] [Full Text] [Related]

  • 3. Retrospective Evaluation of Relationship Between Iron Overload and Transplantation Complications in Pediatric Patient Who Underwent Allogeneic Stem Cell Transplantation Due to Acute Leukemia and Myelodysplastic Syndrome.
    Küpesiz FT, Hazar V, Eker N, Guler E, Yesilipek MA, Tuysuz G, Kupesiz A.
    J Pediatr Hematol Oncol; 2020 Jul; 42(5):e315-e320. PubMed ID: 32427707
    [Abstract] [Full Text] [Related]

  • 4. Iron overload in patients with acute leukemia or MDS undergoing myeloablative stem cell transplantation.
    Armand P, Kim HT, Rhodes J, Sainvil MM, Cutler C, Ho VT, Koreth J, Alyea EP, Hearsey D, Neufeld EJ, Fleming MD, Steen H, Anderson D, Kwong RY, Soiffer RJ, Antin JH.
    Biol Blood Marrow Transplant; 2011 Jun; 17(6):852-60. PubMed ID: 20854920
    [Abstract] [Full Text] [Related]

  • 5. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K, Nishida T, Asano-Mori Y, Oshima K, Ohashi K, Mori T, Kanamori H, Miyamura K, Kato C, Kobayashi N, Uchida N, Nakamae H, Ichinohe T, Morishima Y, Suzuki R, Yamaguchi T, Fukuda T.
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [Abstract] [Full Text] [Related]

  • 6. Epidemiology of bloodstream infections after myeloablative and non-myeloablative allogeneic hematopoietic stem cell transplantation: A single-center cohort study.
    Gjaerde LI, Moser C, Sengeløv H.
    Transpl Infect Dis; 2017 Oct; 19(5):. PubMed ID: 28561378
    [Abstract] [Full Text] [Related]

  • 7. The prognostic value of serum C-reactive protein, ferritin, and albumin prior to allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndromes.
    Artz AS, Logan B, Zhu X, Akpek G, Bufarull RM, Gupta V, Lazarus HM, Litzow M, Loren A, Majhail NS, Maziarz RT, McCarthy P, Popat U, Saber W, Spellman S, Ringden O, Wickrema A, Pasquini MC, Cooke KR, from the Center for International Blood and Marrow Transplantation Research.
    Haematologica; 2016 Nov; 101(11):1426-1433. PubMed ID: 27662010
    [Abstract] [Full Text] [Related]

  • 8. Multicenter validation of scoring system of pre-transplant serum ferritin and disease risk in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic hematopoietic stem cell transplant.
    Tachibana T, Tanaka M, Yamazaki E, Numata A, Takasaki H, Kuwabara H, Fujimaki K, Sakai R, Fujita H, Fujisawa S, Maruta A, Ishigatsubo Y, Kanamori H.
    Leuk Lymphoma; 2013 Jun; 54(6):1318-20. PubMed ID: 22989327
    [No Abstract] [Full Text] [Related]

  • 9. Angiopoietin-2 predicts disease-free survival after allogeneic stem cell transplantation in patients with high-risk myeloid malignancies.
    Kümpers P, Koenecke C, Hecker H, Hellpap J, Horn R, Verhagen W, Buchholz S, Hertenstein B, Krauter J, Eder M, David S, Göhring G, Haller H, Ganser A.
    Blood; 2008 Sep 01; 112(5):2139-48. PubMed ID: 18483397
    [Abstract] [Full Text] [Related]

  • 10. Serum ferritin and disease status at transplantation predict the outcome of allo-SCT in patients with AML or myelodysplastic syndrome.
    Tachibana T, Takasaki H, Tanaka M, Maruta A, Hyo R, Ishigatsubo Y, Kanamori H.
    Bone Marrow Transplant; 2011 Jan 01; 46(1):150-1. PubMed ID: 20383206
    [No Abstract] [Full Text] [Related]

  • 11. Clinical significance of pretransplant serum ferritin on the outcome of allogeneic hematopoietic SCT: a prospective cohort study by the Kanto Study Group for Cell Therapy.
    Tanaka M, Kanamori H, Matsumoto K, Tachibana T, Numata A, Ohashi K, Kobayashi T, Nakaseko C, Kanda Y, Yamazaki E, Fujisawa S, Ooi J, Sakura T, Aotsuka N, Onoda M, Machida S, Kato J, Usuki K, Watanabe R, Taguchi J, Yano S, Saito T, Takahashi S, Sakamaki H, Okamoto S, Kanto Study Group for Cell Therapy.
    Bone Marrow Transplant; 2015 May 01; 50(5):727-33. PubMed ID: 25730191
    [Abstract] [Full Text] [Related]

  • 12. Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy.
    Busca A, Falda M, Manzini P, D'Antico S, Valfrè A, Locatelli F, Calabrese R, Chiappella A, D'Ardia S, Longo F, Piga A.
    Biol Blood Marrow Transplant; 2010 Jan 01; 16(1):115-22. PubMed ID: 19766730
    [Abstract] [Full Text] [Related]

  • 13. Impact of pretransplant serum ferritin level on risk of invasive mold infection after allogeneic hematopoietic stem cell transplantation.
    Dadwal SS, Tegtmeier B, Liu X, Frankel P, Ito J, Forman SJ, Pullarkat V.
    Eur J Haematol; 2015 Mar 01; 94(3):235-42. PubMed ID: 25082161
    [Abstract] [Full Text] [Related]

  • 14. Risk factors for pre- and post-engraftment bloodstream infections after allogeneic hematopoietic stem cell transplantation.
    Kikuchi M, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, Sakamoto K, Kawamura K, Ishihara Y, Sato M, Ashizawa M, Terasako-Saito K, Kimura S, Yamazaki R, Kanda J, Kako S, Nishida J, Kanda Y.
    Transpl Infect Dis; 2015 Feb 01; 17(1):56-65. PubMed ID: 25580541
    [Abstract] [Full Text] [Related]

  • 15. Bloodstream Infection Due to Vancomycin-resistant Enterococcus Is Associated With Increased Mortality After Hematopoietic Cell Transplantation for Acute Leukemia and Myelodysplastic Syndrome: A Multicenter, Retrospective Cohort Study.
    Papanicolaou GA, Ustun C, Young JH, Chen M, Kim S, Woo Ahn K, Komanduri K, Lindemans C, Auletta JJ, Riches ML, CIBMTR® Infection and Immune Reconstitution Working Committee.
    Clin Infect Dis; 2019 Oct 30; 69(10):1771-1779. PubMed ID: 30649224
    [Abstract] [Full Text] [Related]

  • 16. Severity of acute gastrointestinal graft-vs-host disease is associated with incidence of bloodstream infection after adult allogeneic hematopoietic stem cell transplantation.
    Modi A, Rybicki L, Majhail NS, Mossad SB.
    Transpl Infect Dis; 2020 Feb 30; 22(1):e13217. PubMed ID: 31769584
    [Abstract] [Full Text] [Related]

  • 17. Hyperferritinemia is associated with low incidence of graft versus host disease, high relapse rate, and impaired survival in patients with blood disorders receiving allogeneic hematopoietic stem cell grafts.
    Wahlin A, Lorenz F, Fredriksson M, Remberger M, Wahlin BE, Hägglund H.
    Med Oncol; 2011 Jun 30; 28(2):552-8. PubMed ID: 20393815
    [Abstract] [Full Text] [Related]

  • 18. Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation.
    Armand P, Kim HT, Cutler CS, Ho VT, Koreth J, Alyea EP, Soiffer RJ, Antin JH.
    Blood; 2007 May 15; 109(10):4586-8. PubMed ID: 17234738
    [Abstract] [Full Text] [Related]

  • 19. Impact of non-transferrin-bound iron (NTBI) in comparison to serum ferritin on outcome after allogeneic stem cell transplantation (ASCT).
    Hilken A, Langebrake C, Wolschke C, Kersten JF, Rohde H, Nielsen P, Kröger N.
    Ann Hematol; 2017 Aug 15; 96(8):1379-1388. PubMed ID: 28585071
    [Abstract] [Full Text] [Related]

  • 20. Red blood cell transfusion dependence and outcome after allogeneic peripheral blood stem cell transplantation in patients with de novo myelodysplastic syndrome (MDS).
    Platzbecker U, Bornhäuser M, Germing U, Stumpf J, Scott BL, Kröger N, Schwerdtfeger R, Böhm A, Kobbe G, Theuser C, Rabitsch W, Valent P, Sorror ML, Ehninger G, Deeg HJ.
    Biol Blood Marrow Transplant; 2008 Nov 15; 14(11):1217-25. PubMed ID: 18940675
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.